AAAAAA

   
Results: 1-9 |
Results: 9
Novel germline RET mutation segregating with papillary thyroid carcinomas
Authors: Rey, JM Brouillet, JP Fonteneau-Allaire, J Boneu, A Bastie, D Maudelonde, T Pujol, P
Citation: Jm. Rey et al., Novel germline RET mutation segregating with papillary thyroid carcinomas, GENE CHROM, 32(4), 2001, pp. 390-391
Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer
Authors: Brouillet, JP Dujardin, MA Chalbos, D Rey, JM Grenier, J Lamy, PJ Maudelonde, T Pujol, P
Citation: Jp. Brouillet et al., Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer, INT J CANC, 95(4), 2001, pp. 205-208
A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma
Authors: Pujol, P Daures, JP Brouillet, JP Chang, S Rouanet, P Bringer, J Grenier, J Maudelonde, T
Citation: P. Pujol et al., A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma, CANCER, 91(10), 2001, pp. 1854-1861
Semiquantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the oestrogen pathway
Authors: Rey, JM Pujol, P Callier, P Cavailles, V Freiss, G Maudelonde, T Brouillet, JP
Citation: Jm. Rey et al., Semiquantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the oestrogen pathway, J MOL ENDOC, 24(3), 2000, pp. 433-440
Neoadjuvant tamoxifen for operable breast cancer: A need for phase III studies?
Authors: Pujol, P Daures, JP Rouanet, P Hermand, J Domergue, J Grenier, J Maudelonde, T
Citation: P. Pujol et al., Neoadjuvant tamoxifen for operable breast cancer: A need for phase III studies?, CANCER DET, 24(5), 2000, pp. 445-451
Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors
Authors: Roger, P Daures, JP Maudelonde, T Pignodel, C Gleizes, M Chapelle, J Marty-Double, C Baldet, P Mares, P Laffargue, F Rochefort, H
Citation: P. Roger et al., Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors, HUMAN PATH, 31(5), 2000, pp. 593-600
Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer
Authors: Pujol, P Daures, JP Brouillet, JP Maudelonde, T Rochefort, H Grenier, J
Citation: P. Pujol et al., Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer, BR J CANC, 79(5-6), 1999, pp. 909-914
Evaluation of endometrial inflammation by quantification of macrophages, Tlymphocytes, and interleukin-1 and -6 in human endometrium
Authors: Dechaud, H Maudelonde, T Daures, JP Rossi, JF Hedon, B
Citation: H. Dechaud et al., Evaluation of endometrial inflammation by quantification of macrophages, Tlymphocytes, and interleukin-1 and -6 in human endometrium, J AS REPROD, 15(10), 1998, pp. 612-618
Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis
Authors: Pujol, P Rey, JM Nirde, P Roger, P Gastaldi, M Laffargue, F Rochefort, H Maudelonde, T
Citation: P. Pujol et al., Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis, CANCER RES, 58(23), 1998, pp. 5367-5373
Risultati: 1-9 |